15-Year watch begins for patients who received experimental treatment
Disease control
Not yet recruiting
This study is a required long-term follow-up for patients who have already received the treatment MB-105 in a previous trial. It will monitor 40 patients for 15 years to check for any long-term side effects and to see how well the treatment continues to work over time. The main g…
Sponsor: March Biosciences Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC